219 related articles for article (PubMed ID: 12640410)
21. [Pars palana vitrectomy in chronic uveitis].
Karel I; Dotrelová D; Gergelyová K
Cesk Oftalmol; 1991 Mar; 47(2):87-90. PubMed ID: 1913902
[TBL] [Abstract][Full Text] [Related]
22. Clinical predictors and outcomes of pars plana vitrectomy for retained lens material after cataract extraction.
Ho LY; Doft BH; Wang L; Bunker CH
Am J Ophthalmol; 2009 Apr; 147(4):587-594.e1. PubMed ID: 19195636
[TBL] [Abstract][Full Text] [Related]
23. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
Benitez-del-Castillo JM; Martinez-de-la-Casa JM; Pato-Cour E; Méndez-Fernández R; López-Abad C; Matilla M; Garcia-Sanchez J
Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
[TBL] [Abstract][Full Text] [Related]
24. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
Douglas MJ; Scott IU; Flynn HW
Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
[TBL] [Abstract][Full Text] [Related]
25. Pars plana vitrectomy for the management of retained lens material after cataract surgery.
Merani R; Hunyor AP; Playfair TJ; Chang A; Gregory-Roberts J; Hunyor AB; Azar D; Cumming RG
Am J Ophthalmol; 2007 Sep; 144(3):364-70. PubMed ID: 17632068
[TBL] [Abstract][Full Text] [Related]
26. [Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children].
Figueroa MS; Noval S; Contreras I; Arruabarrena C; García-Pérez JL; Sales M; Gil-Cazorla R
Arch Soc Esp Oftalmol; 2010 Dec; 85(12):390-4. PubMed ID: 21354506
[TBL] [Abstract][Full Text] [Related]
27. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
Lopez-Gonzalez R; Loza E; Jover JA; Benitez Del Castillo JM; Mendez R; Hernandez-Garcia C; Pato E
Scand J Rheumatol; 2009; 38(1):58-62. PubMed ID: 18991187
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in open eye injury managed with vitrectomy: retrospective study.
Globocnik Petrovic M; Lumi X; Drnovsek Olup B
Croat Med J; 2004 Jun; 45(3):299-303. PubMed ID: 15185422
[TBL] [Abstract][Full Text] [Related]
29. [Surgical treatment of progressive and symptomatic retinal detachment in senile retinoschisis].
Dotrelová D
Sb Lek; 2002; 103(2):109-31. PubMed ID: 12688133
[TBL] [Abstract][Full Text] [Related]
30. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR
Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
32. [Results of pars plana vitrectomy in chronic uveitis in childhood].
Bacskulin A; Eckardt C
Ophthalmologe; 1993 Oct; 90(5):434-9. PubMed ID: 8219626
[TBL] [Abstract][Full Text] [Related]
33. Short-term outcomes of 23-gauge pars plana vitrectomy.
Gupta OP; Ho AC; Kaiser PK; Regillo CD; Chen S; Dyer DS; Dugel PU; Gupta S; Pollack JS
Am J Ophthalmol; 2008 Aug; 146(2):193-197. PubMed ID: 18547538
[TBL] [Abstract][Full Text] [Related]
34. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
36. Sutureless combined 25-gauge vitrectomy, phacoemulsification, and posterior chamber intraocular lens implantation for management of uveitic cataract associated with posterior segment disease.
Soheilian M; Mirdehghan SA; Peyman GA
Retina; 2008; 28(7):941-6. PubMed ID: 18698295
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of vitrectomy without laser treatment for macular detachment associated with an optic disc pit.
Hirakata A; Okada AA; Hida T
Ophthalmology; 2005 Aug; 112(8):1430-5. PubMed ID: 16024082
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
Walton RC; Nussenblatt RB; Whitcup SM
Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
40. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
